Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-02-20 @ 8:08 PM
Study NCT ID:
NCT02038933
Status:
COMPLETED
Last Update Posted:
2021-10-14
First Post:
2014-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-15
First Submit QC Date:
None
Study First Post Date:
2014-01-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-19
Results First Submit QC Date:
None
Results First Post Date:
2017-05-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-12-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-10-13
Last Update Post Date:
2021-10-14
Last Update Post Date Type:
ACTUAL